Allergy to insulin in a woman with gestational diabetes mellitus: Transient efficiency of continuous subcutaneous insulin lispro infusion

Diabetes and Metabolism

Volumn 29, Issue 4 I, 2003, Pages 432-434

  Durand Gonzalez, K N ^a   Guillausseau, N ^b   Anciaux, M L ^b   Hentschel, V ^b   Gayno, J P ^b  

^a Serv de Diabet et Endocrinologie   (France)

^b NONE

Author keywords

Adverse Effects; Allergy to Insulin; Insulin Analogue Lispro

Indexed keywords

ANTIHISTAMINIC AGENT; INSULIN LISPRO;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; INJECTION SITE; INSULIN PUMP; PREGNANCY DIABETES MELLITUS; PRICK TEST;

EID: 0141621185     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70056-3     Document Type: Article

References (12)

1. Nagai T, Nagai Y, Tomizawa T, Mori M. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern Med, 1997, 36, 575-8
2. Eapen SS, Connor EL, Gern JE. Insulin desensitisation with insulin lispro and a insulin pumpin a 5-year-old child. Ann Allergy Asthma Immunol, 2000, 85, 395-7.
3. Gossain VV, Rovner DR, Mohan K. Systemic Allergy to human (recombinant DNA) insulin. Ann Allergy, 1985, 55, 116-8.
4. Balsells MC, Corcoy RM, Lleonart RB, et al. Primary allergy to human insulin in patient with gestational diabetes. Diabetes Care, 1991, 14, 423-4.
5. Altman JJ, Pehuet M, Slama G, Tchobroutsky C. Three cases of allergic reaction to human insulin. Lancet, 1983, 2, 524.
6. Abraham MR, Al-Sharafi BA, Saavedra GA, Khardori R. Lispro in the treatment ofinsulin allergy. Diabetes Care, 1999, 22, 1916-7.
7. Brange J, Owens DR, Kang S, Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care, 1990, 13, 923-54.
8. Naf S, Esmatjes E, Recasens E, et al. Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care, 2002, 25, 634-5.
9. Selam JL, Slama G. Lispro (Humalog) insulin in practice. Diabetes Metab, 1998, 24, 272-5.
10. Airaghi L, Lorini M, Tedeschi A. The insulin analog aspart: a safe alternative in insulin allergy. Diabetes Care, 2001, 24, 2000.
11. Yasuda H, Nagata M, Moriyama H, et al. Human insulin analog insulin aspart does not cause insuline allergy. Diabetes Care, 2001, 24, 2008-9.
12. Takata H, Kumon Y, Osaki F, et al. The human insulin analogue aspart is not the almighty solution for insulin allergy. Diabetes Care, 2003, 26, 253-4.